Ying J, Zhang M, Wei K, Wong S, Subramaniam M
Front Microbiol. 2025; 15():1401597.
PMID: 39850141
PMC: 11755156.
DOI: 10.3389/fmicb.2024.1401597.
Anaclerio F, Minelli M, Antonucci I, Gatta V, Stuppia L
Biomedicines. 2025; 12(12.
PMID: 39767593
PMC: 11726726.
DOI: 10.3390/biomedicines12122686.
Retuerto M, Al-Shakhshir H, Herrada J, McCormick T, Ghannoum M
Nutrients. 2024; 16(17).
PMID: 39275319
PMC: 11396985.
DOI: 10.3390/nu16173004.
Borrego-Ruiz A, Borrego J
Children (Basel). 2024; 11(7).
PMID: 39062245
PMC: 11275248.
DOI: 10.3390/children11070796.
Li B, Ma Y, Wang X, Zhao D, Wang Z, Wang G
Neurochem Res. 2024; 49(10):2726-2742.
PMID: 38935224
DOI: 10.1007/s11064-024-04168-y.
Mapping the geographical distribution of the mucosa-associated gut microbiome in GI-symptomatic children with autism spectrum disorder.
Reeves K, Figuereo Y, Weis V, Hsu F, Engevik M, Krigsman A
Am J Physiol Gastrointest Liver Physiol. 2024; 327(2):G217-G234.
PMID: 38887795
PMC: 11637567.
DOI: 10.1152/ajpgi.00101.2024.
Neuromodulation and the Gut-Brain Axis: Therapeutic Mechanisms and Implications for Gastrointestinal and Neurological Disorders.
Aljeradat B, Kumar D, Abdulmuizz S, Kundu M, Almealawy Y, Batarseh D
Pathophysiology. 2024; 31(2):244-268.
PMID: 38804299
PMC: 11130832.
DOI: 10.3390/pathophysiology31020019.
Characterization of a Clinically and Biologically Defined Subgroup of Patients with Autism Spectrum Disorder and Identification of a Tailored Combination Treatment.
Perez-Cano L, Boccuto L, Sirci F, Hidalgo J, Valentini S, Bosio M
Biomedicines. 2024; 12(5).
PMID: 38790952
PMC: 11117897.
DOI: 10.3390/biomedicines12050991.
Iron toxicity, ferroptosis and microbiota in Parkinson's disease: Implications for novel targets.
Carvalho F, Landis H, Getachew B, Silva V, Ribeiro P, Aschner M
Adv Neurotoxicol. 2024; 11:105-132.
PMID: 38770370
PMC: 11105119.
DOI: 10.1016/bs.ant.2024.02.001.
Current understanding of the molecular mechanisms of chemotherapy-induced peripheral neuropathy.
Chen X, Gan Y, Au N, Ma C
Front Mol Neurosci. 2024; 17:1345811.
PMID: 38660386
PMC: 11039947.
DOI: 10.3389/fnmol.2024.1345811.
Autism spectrum disorder: pathogenesis, biomarker, and intervention therapy.
Zhuang H, Liang Z, Ma G, Qureshi A, Ran X, Feng C
MedComm (2020). 2024; 5(3):e497.
PMID: 38434761
PMC: 10908366.
DOI: 10.1002/mco2.497.
Intestinal Microbiota Is a Key Target for Load Swimming to Improve Anxiety Behavior and Muscle Strength in Shank 3 Rats.
An S, Zhen Z, Wang S, Sang M, Zhang S
Mol Neurobiol. 2023; 61(12):9961-9976.
PMID: 37966684
DOI: 10.1007/s12035-023-03670-8.
Maternal methyl donor supplementation regulates the effects of cafeteria diet on behavioral changes and nutritional status in male offspring.
Herrera K, Maldonado-Ruiz R, Camacho-Morales A, De la Garza A, Castro H
Food Nutr Res. 2023; 67.
PMID: 37920679
PMC: 10619398.
DOI: 10.29219/fnr.v67.9828.
Interaction of Heavy Metal Lead with Gut Microbiota: Implications for Autism Spectrum Disorder.
Tizabi Y, Bennani S, El Kouhen N, Getachew B, Aschner M
Biomolecules. 2023; 13(10).
PMID: 37892231
PMC: 10605213.
DOI: 10.3390/biom13101549.
Memory Reflections of the Microbiota-Gut and Oligodendrocyte Axis.
Ray S, Mukherjee S
CNS Neurol Disord Drug Targets. 2023; 23(8):971-983.
PMID: 37855297
DOI: 10.2174/0118715273256132230921103333.
CHD8 regulates gut epithelial cell function and affects autism-related behaviors through the gut-brain axis.
Chatterjee I, Getselter D, Ghanayem N, Harari R, Davis L, Bel S
Transl Psychiatry. 2023; 13(1):305.
PMID: 37783686
PMC: 10545671.
DOI: 10.1038/s41398-023-02611-2.
Disgust Processing and Potential Relationships with Behaviors in Autism.
Jayashankar A, Aziz-Zadeh L
Curr Psychiatry Rep. 2023; 25(10):465-478.
PMID: 37672122
PMC: 10627949.
DOI: 10.1007/s11920-023-01445-5.
Could the Urease of the Gut Bacterium Play a Role in the Altered Gut-Brain Talk Associated with Parkinson's Disease?.
Grahl M, Andrade B, Perin A, Neves G, Duarte L, Uberti A
Microorganisms. 2023; 11(8).
PMID: 37630602
PMC: 10459573.
DOI: 10.3390/microorganisms11082042.
Signalling cognition: the gut microbiota and hypothalamic-pituitary-adrenal axis.
Rusch J, Layden B, Dugas L
Front Endocrinol (Lausanne). 2023; 14:1130689.
PMID: 37404311
PMC: 10316519.
DOI: 10.3389/fendo.2023.1130689.
Prevalence of small intestinal bacterial overgrowth in irritable bowel syndrome (IBS): Correlating H or CH production with severity of IBS.
Onana Ndong P, Boutallaka H, Marine-Barjoan E, Ouizeman D, Mroue R, Anty R
JGH Open. 2023; 7(4):311-320.
PMID: 37125253
PMC: 10134763.
DOI: 10.1002/jgh3.12899.